Vitamin B17, known as laetrile, is marketed as an alternative treatment for cancer. When vitamin B17 is used in increased doses, it may help fight cancer. The U.S. Food and Drug Administration does not approve of or control B17. In fact, according to its website, the FDA states: "While some proponents have recommended it for the treatment and control of cancer, these claims have never been approved by the FDA. There are no published clinical studies which demonstrate that Laetrile is safe and effective, and cancer patients who take it sometimes forgo conventional therapies to their detriment."
The benzaldehyde molecule in vitamin B17, also known as amygdalin, is the major reason why the cancer cell may be killed. Apricot kernels contain vitamin B17, and an average of 24 to 40 kernels are needed daily. It must be used with an effective cancer diet. The metabolic diet involved with vitamin B17 causes the enzymes surrounding the cancer cell to break down, thus causing it to become weakened and ready to be destroyed by white blood cells. Vitamin B17 may kill cancer cells and assists the body's immunity system against outbreaks of cancer in the future.
One of the side effects of vitamin B17 in high doses within the body is that vitamin B12 is made. This form of vitamin B12, along with vitamin C, is believed to aid in fighting cancer. These two vitamins also aid in the buildup of trypson and chymotrypsin, which are enzymes in the body that break down the outer shell of the cancer cell, making it vulnerable to be destroyed by white blood cells.
Vitamin B17 along with zinc, magnesium, selium and vitamins A and B cause the body's defense mechanism against cancer to be built up, thus deterring cancer growth within the body. In addition to the noted vitamins, zinc is the transportation system for the disbursement of laetrile in the body, thus building up the immune system against cancer.